课题基金 / 基金详情

ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION

ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION
HCV 和 HIV 感染中的酒精/细胞免疫
批准号:
6619828
负责人:
Kyong-Mi Chang
金额:
$39.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-28 至 2005-07-31

项目摘要

项目成果

Kyong-Mi Chang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Up to 3% of the world population is infected with hepatitis C virus (HCV), a hepatotropic RNA virus that causes acute and chronic hepatitis as well as cirrhosis and hepatocellular carcinoma. HCV infection results in chronicity in most cases (85%) despite detectable antiviral immune response, and recent studies suggest that virus-specific T cells play an important role in the outcome of HCV infection. Interestingly, HCV infection is up to 7 fold more prevalent in alcoholic individuals than in the general population, and chronic alcohol use in HCV-infected patients is associated with accelerated liver disease progression and development of liver cancer. While alcohol is known to suppress cellular immune response, little is known about the effect of alcohol on HCV-specific T cell response in HCV-infected patients. Therefore, the primary aim of this application is to determine if chronic alcohol use results in a pathogenetic HCV-specific T cell response that promotes further liver damage than virus control. In addition, we will determine the extent to which this may be reversed upon alcohol cessation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetics of Cardiometabolic Diseases in the VA Population
Genetics of Cardiometabolic Diseases in the VA Population
Genetics of Cardiometabolic Diseases in the VA Population
  • 批准号:
    10789045
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Kyong-Mi Chang
  • 依托单位:
Genetics of Cardiometabolic Diseases in the VA Population
海外基金